Clinical Trial Update: High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating high-dose aflibercept for diabetic macular edema in patients who have previously undergone vitrectomy. The trial is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Retina Consultants of Orange County | Conditions: Diabetic Macular Edema (DME) | Phase 4 | Status: RECRUITING